TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023InvestorPlace • about 1 month ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of...
Share to Feed
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced...
Gagnants
L'action Genelux (NASDAQ:GNLX) a mont vendredi de 10,06% 7 dollars lors de la session after-market.
L'action Telesis Bio (NASDAQ:TBIO) a mont de 9,28% 0,60 dollars.
Le titre Estrella...
Titoli in rialzo
Le azioni di Genelux (NASDAQ:GNLX) hanno fatto segnare +10,06% a 7 dollari durante la sessione after-market di venerd .
Il titolo Telesis Bio (NASDAQ:TBIO) ha avuto un aumento del...
Telesis Bio, Inc. (NASDAQ:TBIO Get Free Report) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 131,400 shares...
Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expenseSAN DIEGO, Feb. 26, 2024 (GLOBE...